Home / Inspections / 1309054

FDA Inspection 1309054 — New York Presbyterian Hospital Weill Cornell Medical College

New York Presbyterian Hospital Weill Cornell Medical College — FEI 3003972369

The FDA completed an inspection of New York Presbyterian Hospital Weill Cornell Medical College on March 18, 2026 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 18, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)

Facility

Other inspections at this facility

  • 1211289 (NAI Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1109017 (NAI Wed Sep 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 988710 (NAI Wed Sep 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 878683 (NAI Wed May 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 794517 (VAI Mon Aug 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources